Bianchi, S., Lavignolle Heguy, M., Montaner, A., Libertun, C., Lux-Lantos, V., & Bianchi, M. (2019). SAT-172 Continuous, Prolonged Treatment with the Oligonucleotide IMT504 in Diabetic NOD Mice Greatly Improves All Parameters of the Diabetic Condition. J Endocr Soc.
Citación estilo ChicagoBianchi, Stefania, María Lavignolle Heguy, Alejandro Montaner, Carlos Libertun, Victoria Lux-Lantos, y Maria Bianchi. "SAT-172 Continuous, Prolonged Treatment With the Oligonucleotide IMT504 in Diabetic NOD Mice Greatly Improves All Parameters of the Diabetic Condition." J Endocr Soc 2019.
Cita MLABianchi, Stefania, et al. "SAT-172 Continuous, Prolonged Treatment With the Oligonucleotide IMT504 in Diabetic NOD Mice Greatly Improves All Parameters of the Diabetic Condition." J Endocr Soc 2019.